EUR 0.08
(-1.89%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -9.03 Million EUR | -27.85% |
2022 | -3.53 Million EUR | -192.22% |
2021 | -1.2 Million EUR | 18.09% |
2020 | -1.47 Million EUR | 36.52% |
2019 | -2.32 Million EUR | 40.05% |
2018 | -3.87 Million EUR | -358.93% |
2017 | -845 Thousand EUR | 62.56% |
2016 | -2.25 Million EUR | -22.33% |
2015 | -1.84 Million EUR | -4.17% |
2014 | -1.77 Million EUR | -522.32% |
2013 | -284.6 Thousand EUR | -314.97% |
2012 | 132.39 Thousand EUR | 95.24% |
2011 | 67.81 Thousand EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -370 Thousand EUR | 0.0% |
2023 Q4 | -3.26 Million EUR | 0.0% |
2023 Q2 | -890 Thousand EUR | 0.0% |
2023 FY | -4.51 Million EUR | -27.85% |
2022 Q2 | -803 Thousand EUR | 0.0% |
2022 FY | -3.53 Million EUR | -192.22% |
2022 Q4 | -2.28 Million EUR | 0.0% |
2021 FY | -1.2 Million EUR | 18.09% |
2021 Q2 | -491 Thousand EUR | 0.0% |
2021 Q4 | -718 Thousand EUR | 0.0% |
2020 Q4 | -380 Thousand EUR | 0.0% |
2020 FY | -1.47 Million EUR | 36.52% |
2020 Q2 | -1.15 Million EUR | 0.0% |
2019 Q2 | -1.57 Million EUR | 0.0% |
2019 Q4 | 425 Thousand EUR | 0.0% |
2019 FY | -2.32 Million EUR | 40.05% |
2018 Q2 | -1.62 Million EUR | 0.0% |
2018 FY | -3.87 Million EUR | -358.93% |
2018 Q4 | -2.25 Million EUR | 0.0% |
2017 Q2 | 698 Thousand EUR | 0.0% |
2017 FY | -845 Thousand EUR | 62.56% |
2017 Q4 | -1.54 Million EUR | 0.0% |
2016 Q2 | -840 Thousand EUR | 0.0% |
2016 FY | -2.25 Million EUR | -22.33% |
2016 Q4 | -1.41 Million EUR | 0.0% |
2015 FY | -1.84 Million EUR | -4.17% |
2015 Q4 | -878.67 Thousand EUR | 0.0% |
2015 Q2 | -966.31 Thousand EUR | 0.0% |
2014 Q4 | -1.06 Million EUR | 0.0% |
2014 Q2 | -701.74 Thousand EUR | 0.0% |
2014 FY | -1.77 Million EUR | -522.32% |
2013 FY | -284.6 Thousand EUR | -314.97% |
2013 Q4 | 42.82 Thousand EUR | 0.0% |
2013 Q2 | -327.42 Thousand EUR | 0.0% |
2012 Q1 | 35.09 Thousand EUR | 0.0% |
2012 Q2 | 35.09 Thousand EUR | 0.0% |
2012 Q3 | 35.09 Thousand EUR | 0.0% |
2012 Q4 | -96.14 Thousand EUR | -373.93% |
2012 FY | 132.39 Thousand EUR | 95.24% |
2011 Q3 | 803.50 EUR | 0.0% |
2011 Q4 | 35.09 Thousand EUR | 4268.14% |
2011 FY | 67.81 Thousand EUR | 0.0% |
2011 Q1 | 803.50 EUR | 0.0% |
2011 Q2 | 803.50 EUR | 0.0% |
2010 Q4 | 803.50 EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Crossject Société Anonyme | -11.8 Million EUR | 23.441% |
Safe Orthopaedics SA | -5.96 Million EUR | -51.526% |
Amplitude Surgical SA | 13.24 Million EUR | 168.227% |
Sartorius Stedim Biotech S.A. | 484.5 Million EUR | 101.865% |
EssilorLuxottica Société anonyme | 3.17 Billion EUR | 100.284% |
bonyf N.V. | -39.89 Thousand EUR | -22544.958% |